AASLD

AASLD Founded in 1950, AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease.
(1)

šŸ† Four days left to make an impact! The new Impact Award honors members making meaningful contributions across researc...
06/03/2026

šŸ† Four days left to make an impact!

The new Impact Award honors members making meaningful contributions across research, clinical care, education, mentorship, and innovation, with a clear trajectory toward future leadership in the field.

Submit a nomination in less than 10 minutes! Self-nominate or nominate a peer before June 7.

šŸ‘‰ Be part of recognizing excellence across the AASLD community, nominate today: https://bit.ly/4whA86e.

The countdown is on for !Have you registered yet? AASLD members receive an exclusive discount on registration, making n...
06/03/2026

The countdown is on for !

Have you registered yet? AASLD members receive an exclusive discount on registration, making now the perfect time to secure your spot.

Register today and join us June 14ā€“18 in Cape Coral, Florida. https://bit.ly/3PzkNgU

06/02/2026

Hear from an Infectious Disease doctor on what it means to be part of nearly 9,000 attendees from 80+ countries, all brought together at The Liver Meeting. With over 2,400 poster presentations and hundreds of hours of educational content, it's one of the most comprehensive and inclusive gatherings in hepatology.

šŸŒˆHappy from AASLD! This month and every month, AASLD is proud to support and uplift the LGBTQ+ community through educa...
06/01/2026

šŸŒˆHappy from AASLD!

This month and every month, AASLD is proud to support and uplift the LGBTQ+ community through education, advocacy, inclusion, and connection.

From our + webinars and the annual reception at , to the ongoing efforts of the Inclusion and Diversity Committee and Public Policy Committee, AASLD remains committed to creating a more inclusive and welcoming community for all.

AASLD endorses MedscapeĀ® Educationā€™s latest activities focused on improving hepatitis screening, vaccination, patient ...
05/29/2026

AASLD endorses MedscapeĀ® Educationā€™s latest activities focused on improving hepatitis screening, vaccination, patient communication, and team-based care strategies. Are your current workflows working as effectively as they could be? These resources are designed to help healthcare professionals identify and close care gaps.

View the activities: https://bit.ly/49vlrCK

šŸ“£Calling all early-career women in !The deadline to apply for the Womenā€™s Leadership Development Program has been ext...
05/29/2026

šŸ“£Calling all early-career women in !

The deadline to apply for the Womenā€™s Leadership Development Program has been extended to June 26.

Empower your future with this unique opportunity to build leadership skills, connect with senior mentors, and grow your impact in the field.

āž”ļøTake the next step and apply today: https://bit.ly/4u8uVM8

05/29/2026

Hear directly from AASLD Senior Councilor and program chair Rotonya Carr, MD, FACP, FAASLD to see why you should apply for the 2026 AASLD-EASL Masterclass. Applications close on June 15, get started now: https://bit.ly/3Oe7pOx

BREAKING NEWS: A major milestone for people living with .The FDA has approved ( ), the first approved treatment for c...
05/28/2026

BREAKING NEWS: A major milestone for people living with .

The FDA has approved ( ), the first approved treatment for chronic infection.

In this news article, member Ira M. Jacobson, MD, FAASLD, highlights the potential of this long-awaited therapy to help address a significant unmet need for people living with HDV.

Read more: https://bit.ly/4u70DJg.

Join AASLD and the Indian National Association for Study of the Liver on June 11 at 11 a.m. EDT for the annual joint glo...
05/28/2026

Join AASLD and the Indian National Association for Study of the Liver on June 11 at 11 a.m. EDT for the annual joint global webinar in recognition of World MASH Day 2026.

Explore the evolving diagnostic landscape for , including non-invasive testing strategies, emerging therapies like resmetirom and semaglutide, and integrated approaches to managing cardiometabolic comorbidities in MASH patients. Learn More and Register: https://bit.ly/4vcgzL7

This , Chair of the Public Policy Committee, Julius M. Wilder, MD, PhD, FAASLD, highlights a critical message: We hav...
05/27/2026

This , Chair of the Public Policy Committee, Julius M. Wilder, MD, PhD, FAASLD, highlights a critical message: We have made tremendous progress in screening and treatment, but too many people still remain unscreened.

Continued advocacy, innovation, research funding, and action will be essential to advancing equitable access to care and moving closer to hepatitis elimination.

Learn more about AASLD advocacy and policy efforts: https://bit.ly/3YVavso.

Address

1001 N Fairfax Street, 4th Floor
Alexandria, VA
22314

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+17032999766

Website

Alerts

Be the first to know and let us send you an email when AASLD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to AASLD:

Shortcuts

Share